Acutus Medical News and Activities

Acutus Medical is a company listed under the stock ticker AFIB (US).

View the org chart displaying its 10 main executives

Most searched biographies at Acutus Medical

• Takeo Mukai, Chief Executive Officer & Chief Financial Officer
• David Bonita, Director
• Jason Garland, Director

Create your alert
to follow the executive moves at Acutus Medical.

Acutus Medical has 2,341 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Biogen (United States (USA)).

Popular M&A news in Biotechnology

• Regeneron Pharmaceuticals has announced the acquisition of 23andMe  (posted on May 20 2025).
• Stylus Medicine has just announced a $85 Million fundraising (posted on May 16 2025).
• Azafaros has just announced a $132 Million fundraising (posted on May 15 2025).

Popular contacts in Biotechnology

• Sandra Smith - Senior Vice President, Clinical Solutions & Strategic Partnerships at WIRB-Copernicus Group
• Deepika Verma - Associate Director of Data Science and Digitalization at Wheeler Bio
• Steven Gillis - Chairman of the Board at VBI Vaccines

Learn more about the Biotechnology industry

Press releases by Acutus Medical

• Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | Acutus Medical, Inc.
• Acutus Medical to Announce Second Quarter 2022 Financial Results | Acutus Medical, Inc.
• Acutus Medical Announces Approval of its AcQMap System and AcQMap 3D Imaging and Mapping Catheter in Japan | Acutus Medical, Inc.
• Acutus Medical Announces CEO Appointment and Preliminary Second Quarter Revenue Results | Acutus Medical, Inc.
• Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | Acutus Medical, Inc.
• Acutus Medical Completes First Closing of Transaction with Medtronic and Debt Refinancing to Fund Strategic Growth Priorities | Acutus Medical, Inc.
• Acutus Medical Announces FDA Clearance, Commercial Launch of AcQCross™ Line Extension Compatible with Watchman™ Delivery System | Acutus Medical, Inc.
• Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | Acutus Medical, Inc.
• Acutus Medical completes enrollment in IDE trial with its AcQBlate® FORCE Sensing Ablation System | Acutus Medical, Inc.
• Acutus Medical Reports First Quarter 2022 Financial Results and CEO Transition | Acutus Medical, Inc.
• View more press releases Close

Social media about Acutus Medical

• Acutus Medical on Wikipedia, Google News & Yahoo Finance
• Acutus Medical on LinkedIn, Twitter & YouTube